XORTX Therapeutics Ratios (2020-2026) | XRTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)				-134.68%	-100.00%	-100.00%	-73.67%	-100.00%	-100.00%	-140.09%	-183.21%
EBIT Margin (Quarter)				-134.56%	-98.79%	-96.13%	-71.17%	-99.90%	-100.00%	-140.09%	-183.21%
EBITDA Margin (Quarter)				-134.56%	-98.79%	-96.13%	-71.17%	-99.90%	-100.00%	-140.09%	-183.21%
Net Margin (Quarter)				-134.68%	-100.00%	-100.00%	-73.67%	-100.00%	-100.00%	-140.09%
FCF Margin (Quarter)						103.71%	-645.35%	0.20%	0.13%
Efficiency
Assets Average (Quarter)			11.85M	16.02M	13.57M	12.03M	11.91M	11.00M	8.73M	7.22M			5.42M	4.32M	3.97M	3.80M	3.12M	2.78M	2.75M	2.41M
Invested Capital (Quarter)			0.56M
Asset Utilization Ratio (Quarter)							0.52	0.49	0.65	0.80
Leverage & Solvency
Interest Coverage Ratio (Quarter)	0.00M	293.96	-231.77	-0.00M	-81.50	-24.87	-28.48	-981.70
Times Interest Earned (Quarter)	0.00M	293.96	-231.77	-0.00M	-81.50	-24.87	-28.48	-981.70
Dividends & Payouts
FCF Payout Ratio (Quarter)								0.00M	-0.00M
Valuation
Enterprise Value (Quarter)		-3.97M	-14.96M	-12.24M	-10.53M	-9.32M	-10.41M	-7.91M	-6.16M	-5.07M		-3.84M	-3.08M	-2.30M	-2.47M	-1.90M	-1.06M	-1.19M	-0.86M	-0.25M
Return Ratios
Return on Sales (Quarter)				-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%
Return on Capital Employed (Quarter)			-11.78%				-60.06%		-60.36%	-83.04%
Return on Assets (Quarter)			0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	-0.01%	-0.01%			-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.03%	-0.03%